Navigation Links
Anti-Nuclear Antibodies (ANA) Hep-2 Substrate

ProductsAnti-Nuclear Antibodies (ANA) Hep-2 Substrate
Company Inverness Medical Innovations
Item Anti-Nuclear Antibodies (ANA) Hep-2 Substrate
Features All kits include the following:
  • Slides
  • FITC Conjugate
  • Positive & Negative Controls
  • Mounting Media
  • PBS Buffer Packets
  • ZORBA-NS Sample Diluent
Description Inverness Medical Professional Diagnostics is a leading provider of immunofluorescence assays, with an extensive IFA and DFA test menu that includes kits for autoimmune diseases, infectious diseases and STDs as well as miscellaneous conjugates and components. Our Impact IFA Test Systems give you a wide assortment of substrates and kit sizes to choose from. Kit components include substrate slides, controls, conjugate, mounting medium, phosphate-buffered saline (PBS) and ZORBA-NS serum diluents to reduce the nonspecific fluorescence associated with some serum specimens.
Info Inverness Medical Innovations
Customer Service: 800-257-9525
Web site: http://www.invernessmedical.com/

Related medicine products :

1. ImmuLisa Anti-Nuclear Antibody (ANA) Screen ELISA
2. Anti-Nuclear Antibody (ANA) with Reflex to dsDNA, RNP, Smith, SSA, & SSB Antibodies
3. Anti-Nuclear Antibodies (ANA), IgG Screen with Reflex to IFA Titer
4. Anti-GBM Antibodies ELISA
5. Sm/RNP Anti-Extractable Nuclear Antigen (ENA) Antibodies Kit
6. SS-B (La) Anti-Extractable Nuclear Antigen (ENA) Antibodies Kit
7. Sm Anti-Extractable Nuclear Antigen (ENA) Antibodies Kit
8. SS-A (Ro)Anti-Extractable Nuclear Antigen (ENA) Antibodies Kit
9. Adenovirus Antibodies, IgG & IgM
10. ANCA Antibodies (MPO/PR3) by ELISA
11. Anti-Cardiolipin Antibodies, IgG & IgM
Breaking Medicine Technology:Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 2Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 3Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 4ARKRAY, Inc. Receives FDA 510k Clearance on the Assure(R) Platinum Auto-Code Blood Glucose Monitoring System 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 4 242 million grant aids study of lung cancer in people who never smoked 9305 1 242 million grant aids study of lung cancer in people who never smoked 9305 2 242 million grant aids study of lung cancer in people who never smoked 9305 3Genetic tests advertised directly to the consumer 9302 1Genetic tests advertised directly to the consumer 9302 2Lumenis Worlds Largest Medical Laser Company Honored by Premier Healthcare Alliance for Exceeding Performance Expectations 52297 1Lumenis Worlds Largest Medical Laser Company Honored by Premier Healthcare Alliance for Exceeding Performance Expectations 52297 2Lumenis Worlds Largest Medical Laser Company Honored by Premier Healthcare Alliance for Exceeding Performance Expectations 52297 3Lumenis Worlds Largest Medical Laser Company Honored by Premier Healthcare Alliance for Exceeding Performance Expectations 52297 4